The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Synaptic plasticity and mood disorders
Abstract
Recent studies demonstrate that the molecular elements known to regulate neuronal plasticity in models of learning and memory are also involved in the actions of drugs used for the treatment of depression and bipolar disorder. This includes up-regulation of transcription factors, such as the cAMP response element binding protein and neurotrophic factors, such as brain derived neurotrophic factor. These findings raise the possibility that regulation of neural plasticity in specific neuronal circuits is integrally involved in the therapeutic intervention of mood disorders. Atypical antipsychotic drugs, including clozapine and olanzapine, are also effective for the treatment of bipolar disorder, and are used as add-on medication for unipolar depression. The possibility that these atypical antipsychotic drugs also influence the molecular determinants of synaptic plasticity that are involved in the response to drugs used for the treatment of mood disorders, is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The relationship of LTP during waking to increased production of slow waves in sleep is likely relevant for depression, in that most effective antidepressants increase expression of plasticity-related genes (reviewed in Duman, 2002; Payne et al., 2002) much like sleep deprivation (Cirelli et al., 2004), although on a longer time course.”
From Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges (2009) · cites this paper as Duman, 2002
Citations
Cites
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,908
McEwen, B. S., & Sapolsky, R. M. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80028-x · Cited by 1,889
Hippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
Research works printed but not linked: 4
- Thome J, Sakai N, Shin KH, Steffen C, Impey S, Storm DR et al. Regulation of cAMP-response-element promoter activity by antidepressant treatment in CRE-lacZ transgenic mice Soc Neurosci 1998 24: 1844
- Shirayama Y, Chen ACH, Duman RS . Antidepressant-like effects of BDNF and NT-3 in behavioral models of depression Soc Neurosci 2000 26: 1042
- Jacobs B, Fornal CA . Chronic fluoxetine treatment increases hippocampal neurogenesis in rats: a novel theory of depression Soc Neurosci Abstracts, Miami, FL 1999
- Kim J-E, Nakagawa S, Duman RS . Chronic administration of rolipram, a cAMP phosphodiesterase-4 inhibitor, upregulates neurogenesis in the adult mouse hippocampus Soc Neurosci Abs 2000 26: 2316
Cited by
Sorted by citations
Items 101–200 of 363
Wilkie, M. J. V., Smıth, D. J., Reid, I., Day, R. K., Matthews, K., Wolf, C. R., Blackwood, D., & Smith, G. C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32801a3be6 · Cited by 79
Okada, T., Hashimoto, R., Numakawa, T., Iijima, Y., Kosuga, A., Tatsumi, M., Kamijima, K., Kato, T., & Kunugi, H. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001822 · Cited by 74
Zai, G. C., Zai, C. C. H., Chowdhury, N. I., Tiwari, A. K., de Souza, R. P., Lieberman, J. A., Meltzer, H. Y., Potkin, S. G., Müller, D. J., & Kennedy, J. L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.014 · Cited by 74
Caraci, F., Calabrese, F., Molteni, R., Bartova, L., Dold, M., Leggio, G. M., Fabbri, C., Mendlewicz, J., Racagni, G., Kasper, S. F., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014977 · Cited by 76
Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level
Elfving, B., Buttenschøn, H. N., Foldager, L., Poulsen, P. H. P., Andersen, J. H., Grynderup, M. B., Hansen, Å. M., Kolstad, H. A., Kærlev, L., Mikkelsen, S., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.05.003 · Cited by 75
Drugs related to monoamine oxidase activity
Fišar, Z. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.012 · Cited by 73
Ahmadalipour, A., Sadeghzadeh, J., Vafaei, A. A., Bandegi, A. R., Mohammadkhani, R., & Rashidy‐Pour, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.015 · Cited by 71
Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology
Quiroz, J. A., Singh, J. B., Gould, T. D., Denicoff, K. D., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001521 · Cited by 71
Antidepressant-like effects of paeoniflorin on post-stroke depression in a rat model
Hu, M., Wang, A., Zhao, Z.-Y., Chen, X., Li, Y., & Liu, B. (2019) · Neurological Research · doi:10.1080/01616412.2019.1576361 · Cited by 69
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease
Aboukhatwa, M. A., Dosanjh, L. E., & Luo, Y. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-10 · Cited by 70
BDNF Genetic Variations Increase the Risk of Alzheimer's Disease-Related Depression
Borroni, B., Grassi, M., Archetti, S., Costanzi, C., Bianchi, M., Caimi, L., Caltagirone, C., Luca, M. D., & Padovani, A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1191 · Cited by 68
Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression
Borroni, B., Archetti, S., Costanzi, C., Grassi, M., FERRARI, M. M. H., Radeghieri, A., Caimi, L., Caltagirone, C., Luca, M. D., & Padovani, A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.023 · Cited by 69
The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats
Torregrossa, M. M., Isgor, C., Folk, J. E., Rice, K. C., Watson, S. J., & Woods, J. H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300345 · Cited by 67
Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients
Bumb, J. M., Aksay, S. S., Janke, C., Kranaster, L., Geisel, O., Gass, P., Hellweg, R., & Sartorius, A. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0543-3 · Cited by 69
Zhu, W., Bijur, G. N., Styles, N. A., & Li, X. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.03.019 · Cited by 66
Segawa, M., Morinobu, S., Matsumoto, T., Fuchikami, M., & Yamawaki, S. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000053 · Cited by 66
Hashimoto, K., Koizumi, H., Nakazato, M., Shimizu, E., & Iyo, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.01.007 · Cited by 65
Brain-immune crosstalk in the treatment of major depressive disorder
Branchi, I., Poggini, S., Capuron, L., Benedetti, F., Poletti, S., Tamouza, R., Drexhage, H. A., Penninx, B. W. J. H., & Pariante, C. M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.016 · Cited by 66
Dremencov, E., Gur, E., Lerer, B., & Newman, M. E. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00123-4 · Cited by 65
González-Pinto, A. M., Mosquera, F., Palomino, A., Alberich, S., Gutiérrez, A., Haidar, K., Vega, P., Barbeito, S., Jauregi, A. O., & Matute, C. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328338bc5a · Cited by 63
Satomura, E., Baba, H., Nakano, Y., Maeshima, H., Suzuki, T., & Arai, H. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.041 · Cited by 63
Genome-Wide Profiling of the Activity-Dependent Hippocampal Transcriptome
Hermey, G., Mahlke, C., Gutzmann, J. J., Schreiber, J., Blüthgen, N., & Kuhl, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076903 · Cited by 60
Hu, Y., Yu, X., Yang, F., Si, T., Wang, W., Tan, Y., Zhou, D., Wang, H., & Chen, D. (2010) · Journal of Ect · doi:10.1097/yct.0b013e3181c18bbf · Cited by 63
Lin, E., Hong, C., Hwang, J., Liou, Y., Yang, C.-H., Cheng, D., & Tsai, S. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0871 · Cited by 59
Naumenko, V. S., Kondaurova, E. M., Базовкина, Д. В., Tsybko, A. S., Tikhonova, M. A., Kulikov, A. V., & Popova, N. K. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.031 · Cited by 60
Chronic amphetamine treatment reduces NGF and BDNF in the rat brain
Angelucci, F., Gruber, S. H. M., Khoury, A. E., Tonali, P. A., & Mathé, A. A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.002 · Cited by 57
Kozlovsky, N., Matar, M. A., Kaplan, Z., Kotler, M., Zohar, J., & Cohen, H. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.04.009 · Cited by 56
Kunugi, H., Hashimoto, R., Yoshida, M., Tatsumi, M., & Kamijima, K. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30062 · Cited by 56
Advances in the treatment of anxiety: Targeting glutamate
Simon, A. B., & Gorman, J. M. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.005 · Cited by 58
Rh, K., Hs, C., Wong, M., Choi, M., Park, J. Y., Lee, H., Jung, I., Joe, S.-H., Kim, L., Kim, S., et al. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109105457 · Cited by 55
Ito, S., Nitta, Y., Fukumitsu, H., Soumiya, H., Ikeno, K., Nakamura, T., & Furukawa, S. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/139140 · Cited by 55
Antipsychotic drugs cause glial cell line–derived neurotrophic factor secretion from C6 glioma cells
Shao, Z., Dyck, L. E., Wang, H., & Li, X. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0604 · Cited by 54
MicroRNA as therapeutic targets for treatment of depression
Obrietan, K. H., & Hansen, K. F. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s34811 · Cited by 55
Exercise and Bipolar Disorder: A Review of Neurobiological Mediators
Alsuwaidan, M. T., Kucyi, A., Law, C. W. Y., & McIntyre, R. S. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8079-9 · Cited by 54
Iwata, M., Shirayama, Y., Ishida, H., & Kawahara, R. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.060 · Cited by 52
The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety‐related traits
Arias, B., Aguilera, M., Moya-Higueras, J., Sáiz, P. A., Villa, H., Ibáñez, M. I., García‐Portillo, M. P., Bobes, J., Ortet, G., & Fañanás, L. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01764.x · Cited by 54
ADHD pharmacogenetics across the life cycle: New findings and perspectives
Bruxel, E. M., Akutagava-Martins, G. C., Salatino-Oliveira, A., Contini, V., Kieling, C., Hutz, M., & Rohde, L. (2014) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32240 · Cited by 44
Applying ketamine to alleviate the PTSD-like effects by regulating the HCN1-related BDNF
Hou, L., Qi, Y., Sun, H., Wang, G., Li, Q., Wang, Y., Zhang, Z., Du, Z., & Sun, L. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.019 · Cited by 52
Disrupted in schizophrenia 1: building brains and memories
Porteous, D. J., & Millar, J. K. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.04.009 · Cited by 51
Neurotrophin signalling in the human nervous system
Ateaque, S., Merkouris, S., & Barde, Y. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1225373 · Cited by 48
Changes in rat hippocampal CA1 synapses following imipramine treatment
Chen, F., Madsen, T. M., Wegener, G., & Nyengaard, J. R. (2008) · Hippocampus · doi:10.1002/hipo.20423 · Cited by 50
Investigation of mitochondrial DNA copy number in patients with major depressive disorder
Chung, J. K., Lee, S. Y., Park, M., Joo, E.-J., & Kim, S. A. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112616 · Cited by 48
Jutkiewicz, E. M., Torregrossa, M. M., Sobczyk‐Kojiro, K., Mosberg, H. I., Folk, J. E., Rice, K. C., Watson, S. J., & Woods, J. H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.002 · Cited by 48
Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice
Wang, J., Flaisher-Grinberg, S., Li, S., Liu, H., Sun, L., Zhou, Y., & Einat, H. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.07.042 · Cited by 46
Payne, J. L., Quiroz, J. A., Zarate, C. A., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01676-1 · Cited by 46
Modulation of Neural Networks by Interleukin-1
Nemeth, D. P., & Quan, N. (2020) · Brain Plasticity · doi:10.3233/bpl-200109 · Cited by 46
Bayani, A., Hadaeghi, F., Jafari, S., & Murray, G. (2017) · Chronobiology International · doi:10.1080/07420528.2016.1272608 · Cited by 47
Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania
Frey, B. N., Andreazza, A. C., Rosa, A. R., Martins, M. R., Valvassori, S. S., Réus, G. Z., Hatch, J. P., Quevedo, J., & Kapczinski, F. P. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000205013.59455.09 · Cited by 46
Guest, P. C., Knowles, M. R., Molon-Noblot, S., Salim, K., Smith, D., Murray, F., Laroque, P., Hunt, S. P., Felipe, C. D., Rupniak, N. M. J., et al. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.064 · Cited by 46
Aggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington’s disease
Tanaka, M., Ishizuka, K., Nekooki-Machida, Y., Endo, R., Takashima, N., Sasaki, H., Komi, Y., Gathercole, A., Huston, E., Ishii, K., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci85594 · Cited by 45
A Major Depression Prognosis Calculator Based on Episode Duration
Patten, S. B. (2006) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-2-13 · Cited by 48
Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response
de Souza, R. P., Romano‐Silva, M. A., Lieberman, J. A., Meltzer, H. Y., MacNeil, L. T., Culotti, J. G., Kennedy, J. L., & Wong, A. H. C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.01.002 · Cited by 45
Neurotrophic factors in depression in response to treatment
Buttenschøn, H. N., Foldager, L., Elfving, B., Poulsen, P. H. P., Uher, R., & Mors, O. N. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.027 · Cited by 44
Head-out immersion in hot water increases serum BDNF in healthy males
Kojima, D., Nakamura, T., Banno, M., Umemoto, Y., Kinoshita, T., Ishida, Y., & Tajima, F. (2017) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1394502 · Cited by 47
Jang, B., Kim, H. R., Lim, S., Jang, K.-W., & Kim, D. (2008) · Psychiatry Investigation · doi:10.4306/pi.2008.5.3.193 · Cited by 47
Lauer, M., Beckmann, H., & Senitz, D. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00122-1 · Cited by 45
Amidfar, M., Réus, G. Z., Quevedo, J., & Kim, Y.-K. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.03.023 · Cited by 43
Atypical antipsychotics in bipolar depression: Neurobiological basis and clinical implications
Brugue, E., & Vieta, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.014 · Cited by 54
Kim, Y., Zhang, Y., Pang, K., Kang, H., Park, H., Lee, Y., Lee, B., Lee, H., Kim, W.-K., Geum, D., et al. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.6.296 · Cited by 44
Cooke, J. D., Grover, L. M., & Spangler, P. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.037 · Cited by 44
Strauss, J., Barr, C. L., George, C. J., Ryan, C. M., King, N., Shaikh, S., Kovacs, M., & Kennedy, J. L. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:3:181 · Cited by 42
Nerve growth factor (NGF) has novel antidepressant-like properties in rats
Overstreet, D. H., Fredericks, K., Knapp, D., Breese, G., & McMichael, J. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.11.010 · Cited by 42
Pinna, G., Brödel, O., Eravci, M., Stoltenburg, G., Plueckhan, H., Fuxius, S., MEINHOLD, H., & Baumgartner, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00414-1 · Cited by 40
Early Life Sleep Deprivation: Role of Oxido-Inflammatory Processes
Atrooz, F., Liu, H., Kochi, C., & Salim, S. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.02.021 · Cited by 41
Xia, B., Liu, X., Li, X., Wang, Y., Wang, D., Kou, R.-W., Zhang, L., Shi, R., Ye, J., Bo, X., et al. (2022) · Food & Function · doi:10.1039/d1fo03888e · Cited by 41
Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain
STRECK, E. L., Rezin, G. T., Barbosa, L. M., Assis, L. C., Grandi, E., & Quevedo, J. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0178-2 · Cited by 41
Lithium Reduces FoxO3a Transcriptional Activity by Decreasing Its Intracellular Content
Mao, Z., Liu, L., Zhang, R., & Li, X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.006 · Cited by 40
Lesch, K., & Mößner, R. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_18 · Cited by 42
Molecular assessment of depression from mRNAs in the peripheral leukocytes
Iga, J., Ueno, S., & Ohmori, T. (2008) · Annals of Medicine · doi:10.1080/07853890802082088 · Cited by 40
Leggio, G. M., Torrisi, S. A., Castorina, A., Platania, C. B. M., Impellizzeri, A. A. R., Fidilio, A., Caraci, F., Bucolo, C., Drago, F., & Salomone, S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.004 · Cited by 38
Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder
Chang, Y.-H., Lee, S.-Y., Chen, S., Tzeng, N., Wang, T., Lee, I. H., Chen, P. S., Huang, S., Yang, Y. K., Ko, H.-C., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.08.017 · Cited by 36
Ende, G., Demirakça, T., & Tost, H. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)56027-3 · Cited by 37
Koizumi, H., Hashimoto, K., & Iyo, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05094.x · Cited by 37
Down-regulation of the Trk-B signal pathway: the possible pathogenesis of major depression
Tsai, S. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00299-8 · Cited by 37
Intracellular Signalling Pathways and Mood Disorders
Fišar, Z., & Hroudová, J. (2010) · Folia Biologica · doi:10.14712/fb2010056040135 · Cited by 36
Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants
Crozatier, C., Farley, S., Mansuy, I. M., Dumas, S., Bruno Giros, A., & Tzavara, E. T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.030 · Cited by 36
Karege, F., Schwald, M., & Kouaissi, R. E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300384 · Cited by 35
Culm, K. E., Lugo‐Escobar, N., Hope, B. T., & Hammer, R. P. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300483 · Cited by 36
Getting balance: Drugs for bipolar disorder share target
Coyle, J. T., & Manji, H. K. (2002) · Nature Medicine · doi:10.1038/nm0602-557 · Cited by 35
Tsai, S. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.10.009 · Cited by 35
Grande, I., Kapczinski, F. P., Stertz, L., Colpo, G. D., Kunz, M., Ceresér, K. M., Kauer‐Sant’Anna, M., Frey, B. N., Vieta, E., & Magalhães, P. V. D. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.017 · Cited by 33
Candidate genes for panic disorder: insight from human and mouse genetic studies
Gratacòs, M., Sahún, I., Gallego, X., Amador‐Arjona, A., Estivill, X., & Dierssen, M. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00318.x · Cited by 33
Farvolden, P., Kennedy, S. H., & Lam, R. W. M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.65 · Cited by 33
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression
Ramaekers, J. G., Reckweg, J. T., & Mason, N. L. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230890 · Cited by 35
Biological and Behavioral Patterns of Post-Stroke Depression in Rats
Ifergane, G., Boyko, M., Frank, D., Shiyntum, H. N., Grinshpun, J., Kuts, R., Geva, A. B., Kaplan, Z., Zeldetz, V., & Cohen, H. (2018) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2017.302 · Cited by 32
Tsai, S. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.06.005 · Cited by 32
Atypical antipsychotics in the treatment of mood disorders
Vieta, E. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200301000-00006 · Cited by 33
Rethinking the role of TRKB in the action of antidepressants and psychedelics
Brunello, C. A., Cannarozzo, C., & Castrén, E. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.08.011 · Cited by 31
Men navigating inward and outward through depression.
Ramirez, J., & Badger, T. (2014) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2013.10.001 · Cited by 35
Lee, S., Kim, D. H., Yoon, S., & Ryu, J. H. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.017 · Cited by 31
Iñiguez, S. D., Warren, B. L., Neve, R. L., Nestler, E. J., Russo, S. J., & Bolaños‐Guzmán, C. A. (2008) · Behavioral Neuroscience · doi:10.1037/a0012893 · Cited by 30
Murphy, B., Pang, T. Y., Hannan, A. J., Proffitt, T., McConchie, M., Kerr, M., Markulev, C., O’Donnell, C. P., McGorry, P. D., & Berger, G. E. (2014) · Schizophrenia Research and Treatment · doi:10.1155/2014/719395 · Cited by 30
Depression, antidepressants, and peripheral blood components.
Fišar, Z., & Raboch, J. (2008) · PubMed · Cited by 30
Xiao, X., Zhang, H., Ning, W., Yang, Z. R., Wang, Y., & Zhang, T. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114060 · Cited by 29
Mechanisms of action of brain insulin against neurodegenerative diseases
Ramalingam, M., & Kim, S. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1147-1 · Cited by 30
Lee, S.-Y., Wang, T., Chen, S., Chang, Y.-H., Chen, P. S., Huang, S., Tzeng, N., Wang, L., Lee, I. H., Chen, K. C., et al. (2016) · Scientific Reports · doi:10.1038/srep37950 · Cited by 27
Kulikov, A. V., Tikhonova, M. A., Kulikova, E. A., Volcho, K. P., Khomenko, T. M., Salakhutdinov, N. F., & Popova, N. K. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2594-8 · Cited by 28
Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase
Fišar, Z. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.010 · Cited by 28
Pro-apoptotic Action of Corticosterone in Hippocampal Organotypic Cultures
Kurek, A., Kucharczyk, M. W., Detka, J., Ślusarczyk, J., Trojan, E., Głombik, K., Bojarski, B., Ludwikowska, A., Lasoń, W., & Budziszewska, B. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9630-8 · Cited by 26
Hadaeghi, F., Golpayegani, M. R., Jafari, S., & Murray, G. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416642022 · Cited by 26
Metadata
- Authors
- Duman, R. S.
- Affiliations
- Yale University (US)
- Corresponding author
- Duman, R S
- ORCID
- Duman, R S
- Venue
- Molecular Psychiatry
- Published
- 2002-01
- Volume
- 7
- Issue
- S1
- Pages
- S29-S34
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1983914274
- Cited by
- 363
- References
- 46
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 4 · 2020: 11 · 2019: 6 · 2018: 12 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 12 · 2013: 18 · 2012: 21
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (2P01 MH25642, MH-45481, P01MH025642)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- synaptic plasticity, mood disorders, depression, bipolar disorder, CREB, brain-derived neurotrophic factor, neurotrophic factors, transcription factors, atypical antipsychotics, clozapine, olanzapine, neural circuits, antidepressant mechanism
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Humans, Synaptic Transmission, Neuronal Plasticity, Cyclic AMP Response Element-Binding Protein, Brain-Derived Neurotrophic Factor, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review